DrStockPick.com Stock Report!
Tuesday September 8, 2009
AvalonBay Communities, Inc. (NYSE:AVB) announced today that it has commenced a cash tender offer (the “Tender Offer”) for up to $300,000,000 in aggregate principal amount (the “Maximum Principal Amount”) of AvalonBay’s outstanding 7.500% Medium-Term Notes due December 15, 2010 (the “7.500% Notes”), 6.625% Medium-Term Notes due September 15, 2011 (the “6.625% Notes”), 5.500% Medium-Term Notes due January 15, 2012 (the “5.500% Notes”) and 6.125% Medium-Term Notes due November 1, 2012 (the “6.125% Notes”) at a purchase price per $1,000 principal amount, in each case, as set forth in the table below and on the terms and conditions set forth in AvalonBay’s Offer to Purchase dated September 8, 2009 (the “Offer to Purchase”) and the related Letter of Transmittal. The 7.500% Notes, the 6.625% Notes, the 5.500% Notes and the 6.125% Notes are referred to herein collectively as the “Notes.”
Cyclone Power Technologies (Pink Sheets: CYPW) has retained the CPA firm of Mallah, Furman & Company P.A. to audit the company’s financial statements for the periods ended December 31, 2008 and 2009, in compliance with GAAP and accounting regulations of the Securities and Exchange Commission.
Adeona Pharmaceuticals, Inc. (AMEX: AEN), a specialty pharmaceutical company dedicated to the awareness, diagnosis, prevention and treatment of zinc deficiency and chronic copper toxicity in the mature population, today announced the initial formation of its sales and marketing team and pre-launch efforts for its CopperProof serum-based copper/zinc diagnostic panel, which will be offered through Adeona’s Hartlab subsidary. The CopperProof panel is a diagnostic test panel intended to provide a comprehensive look at the metabolic serum copper and zinc status of patients with Alzheimer’s disease (AD) and mild cognitive impairment (MCI). Defects in copper metabolism and high free copper levels are increasingly being recognized as significant factors in the progression of neurodegenerative diseases, including AD and MCI. A clinical zinc deficiency in AD patients has also been recognized for the first time in a recent Adeona-sponsored clinical study.
Windstream Corporation (NYSE: WIN) today announced it has entered into a definitive agreement to acquire Lexcom, Inc., based in Lexington, N.C., for approximately $141 million in cash.
CAS Medical Systems, Inc. (Nasdaq:CASM) today announced the recent completion of a multi-year purchase and sale agreement with one of America’s largest not-for-profit health care providers, serving over 8 million members. Under the terms of this agreement, the hospital system will purchase CASMED’s blood pressure cuffs for its network of over 30 hospitals and more than 400 associated physician offices and medical centers. The agreement includes CASMED’s SoftCheck(r) Disposable and UltraCheck(r) Reusable BP Cuffs.
Abraxas Petroleum Corporation (NASDAQ:AXAS) today announced that it has filed a definitive proxy statement with the Securities and Exchange Commission (”SEC”) in connection with the transactions contemplated by the merger with Abraxas Energy Partners, L.P. The proxy statement was first mailed to stockholders on or about September 8, 2009.
No comments:
Post a Comment